文献速递皮肤感染

激光治疗糖尿病足溃疡风险患者甲真菌病的随机四盲假对照试验

Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1).
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-09

单中心随机四盲假对照试验纳入64例有糖尿病足溃疡风险且临床怀疑甲真菌病的糖尿病患者,随机接受四次Nd-YAG 1064 nm激光或假治疗。主要结局为1年随访后临床和微生物学治愈,结果显示激光与假治疗无差异。除激光治疗后第5趾甲下血肿外,治疗安全性良好。

要点

  • Nd-YAG 1064 nm激光治疗糖尿病足溃疡风险患者甲真菌病1年后未见优于假治疗。
  • 最常见病原体为红色毛癣菌。
  • 除一例趾甲下血肿外,激光治疗安全性良好。

核心结论

  • 在有足溃疡风险的糖尿病患者中,Nd-YAG 1064 nm激光治疗甲真菌病至少1年内未见任何效果证据。

研究设计与样本

  • 单中心、随机(1:1)、四盲、假对照试验,纳入有糖尿病足溃疡风险(Sims分类评分1、2)且临床怀疑甲真菌病并经微生物学确认的糖尿病患者。
  • 共64例患者随机,63例可分析;干预为四次Nd-YAG 1064 nm激光或假治疗;主要结局为1年随访后临床和微生物学治愈。

主要发现

  • 激光与假治疗在主要结局上无差异。
  • 最常检测到的病原体为红色毛癣菌。
  • 除激光治疗后2周第5趾甲下血肿外,结果提示Nd-YAG 1064 nm激光治疗安全。

临床怎么用

  • 对于有足溃疡风险的糖尿病患者,不应依据本试验结果采用Nd-YAG 1064 nm激光治疗甲真菌病。

局限性

  • 单中心研究,样本量63例可分析。
  • 结论仅适用于1年随访期内。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with diabetes mellitus are at high risk for onychomycosis, which is related to the development of foot ulcers. OBJECTIVE: The aim of this study was to evaluate the safety and efficacy of the treatment of onychomycosis with local laser therapy. METHODS: In a single-centre, randomized (1:1), quadruple-blind, sham-controlled trial, patients and microbiological confirmation with diabetes mellitus, at risk for developing diabetic foot ulcers (Sims classification score 1, 2) and a clinical suspicion on onychomycosis, were randomized to either four sessions neodymium-doped yttrium aluminium garnet (Nd-YAG) 1064 nm laser or sham treatment. The primary outcome was clinical and microbiological cure of onychomycosis after 1-year follow-up. RESULTS: From March 2015 to July 2016, 64 patients were randomized; 63 could be analysed. Trichophyton rubrum was the most detected pathogen. There was no difference in the primary outcome between laser and sham treatment. With the exception of a subungual haematoma in the fifth toenail occurring 2 weeks after laser treatment, the results suggested that treatment with Nd-YAG 1064 nm laser is safe. CONCLUSION: At this moment, there is no evidence of any effect of laser treatment for onychomycosis in patients with diabetes at increased risk for foot ulcers, at least not within 1 year after treatment.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Nijenhuis-Rosien L, Kleefstra N, van Dijk PR, et al. Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1). J Eur Acad Dermatol Venereol. 2019. PMID: 30920059. doi:10.1111/jdv.15601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。